Serina Therapeutics Inc (SER) — Strategic Asset Allocation Index

Latest as of September 2025: 56.0%

Serina Therapeutics Inc (SER) has a Strategic Asset Allocation Index of 56.0% as of September 2025. Strategic assets (PP&E of $892.00K plus long-term investments of $-) total $892.00K, measured against net assets of $1.59 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

56.0%
Strategic Assets / Net Assets

Strategic Assets

$892.00K
PP&E + LT Investments

PP&E

$892.00K
USD

Net Assets

$1.59 Million
USD

Serina Therapeutics Inc Strategic Asset Allocation Index (2024–2024)

This chart shows how Serina Therapeutics Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2024 to 2024. As of September 2025, the index stands at 56.0%, representing strategic assets of $892.00K against net assets of $1.59 Million USD. Explore Serina Therapeutics Inc cash conversion from operations to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Serina Therapeutics Inc (2024–2024)

The table below presents the year-by-year Strategic Asset Allocation Index for Serina Therapeutics Inc from 2024 to 2024, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Serina Therapeutics Inc (SER) market capitalisation.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2024 206.3% $1.05 Million $1.05 Million $- $508.00K
pp = percentage points